Baker Avenue Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-63	Closed	-$21.9K	–	1471
2023 Q3	$21.9K	Buy	63 +1	+2%	+$350	﹤0.01%	641
2023 Q2	$21.8K	Sell	62 -7	-10%	-$2.36K	﹤0.01%	632
2023 Q1	$21.7K	Sell	69 -1,591	-96%	-$477K	﹤0.01%	650
2022 Q4	$479K	Sell	1,660 -59	-3%	-$18K	0.03%	250
2022 Q3	$498K	Buy	+1,719	New	+$495K	0.03%	236
2021 Q1	–	Sell	-2,238	Closed	-$528K	–	256
2020 Q4	$528K	Sell	2,238 -3,534	-61%	-$811K	0.04%	168
2020 Q3	$1.57M	Buy	5,772 +677	+13%	+$187K	0.12%	98
2020 Q2	$1.48M	Sell	5,095 -331	-6%	-$89.7K	0.12%	99
2020 Q1	$1.29M	Sell	5,426 -596	-10%	-$137K	0.15%	64
2019 Q4	$1.32M	Sell	6,022 -1,693	-22%	-$343K	0.1%	132
2019 Q3	$1.31M	Buy	7,715 +539	+8%	+$95.4K	0.1%	118
2019 Q2	$1.31M	Buy	7,176 +241	+3%	+$42.1K	0.11%	121
2019 Q1	$1.27M	Buy	+6,935	New	+$1.28M	0.11%	122
2016 Q4	–	Sell	-5,570	Closed	-$486K	–	210
2016 Q3	$486K	Buy	+5,570	New	+$526K	0.07%	140